Skip to main content

Arrowhead Pharmaceuticals, Inc.

ARWR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0000879407

In the last 90 days, Arrowhead Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 2 sales; 501 institutions reported holding it in 13F filings for Q2 2026, worth $9.73B in total; no superinvestor holds it.

Members of Congress who traded ARWR

Since 2020, newest trade first. Options and trades reported under an earlier ticker are included.

Trades
1
Filings
1
Members
1
Buys / sells
0 / 1
Estimated volume
$8.00K
Sum of range midpoints
Members of Congress who traded ARWR
MemberTradesBuys / sellsEst. volumeLast tradedLast filed
Daniel S. GoldmanDemocrat · House · NY10 / 1$8.00KJan 31, 2023Feb 24, 2023

Trades

Every reported trade in Arrowhead Pharmaceuticals, Inc., newest filings first.

Congress trades
MemberAssetTypeOwnerTradedFiledDelayAmountSource
Daniel S. GoldmanDemocrat · House · NYARWRArrowhead Pharmaceuticals, Inc.SellSelfJan 31, 2023Feb 24, 202324 days$1K-$15KFiling

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.